Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?

被引：1
|
作者：
Fagni, Filippo [1 ,2 ]
Simon, David [1 ,2 ,3 ]
机构：
[1] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Ulmenweg 18, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ FAU Erlangen Nurnberg, Deutsch Zentrum Immuntherapie, Erlangen, Germany
[3] Univ Klinikum Erlangen, Ulmenweg 18, D-91054 Erlangen, Germany
来源：
RHEUMATOLOGY | 2022年 / 61卷 / 05期
关键词：
INHIBITOR; RITUXIMAB;
D O I：
10.1093/rheumatology/keab750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1758 / 1759
页数：2
相关论文
共 50 条
  • [41] Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis
    Leong, Joanna Wai Yee
    Cheung, Peter P.
    Dissanayake, Sajeewani
    Fong, Warren Weng Seng
    Leong, Keng Hong
    Leung, Ying Ying
    Lim, Anita Yee Nah
    Lui, Nai Lee
    Manghani, Mona
    Santosa, Amelia
    Sriranganathan, Melonie Kannamma
    Suresh, Ernest
    Tan, Teck Choon
    Teng, Gim Gee
    Lahiri, Manjari
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (02) : 140 - 152
  • [42] Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry
    Kim, J.
    Shin, K.
    Jung, J.
    Suh, C.
    Lee, S.
    Kim, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 1781 - 1791
  • [43] Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus
    Chen, Sarah K.
    Lee, Hemin
    Jin, Yinzhu
    Liu, Jun
    Kim, Seoyoung C.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (02) : 1 - 11
  • [44] LONG-TERM TREATMENT OF RHEUMATOID-ARTHRITIS WITH CYCLOSPORINE-A
    KRUGER, K
    SCHATTENKIRCHNER, M
    PETERSEN, AK
    SHAND, N
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 128 - 128
  • [45] CALCITONIN IN THE LONG-TERM TREATMENT OF CHRONIC RHEUMATOID-ARTHRITIS
    KRUGER, K
    SCHATTENKIRCHNER, M
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 287 - 287
  • [46] Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis
    Petrov, V. I.
    Babaeva, A. R.
    Cherevkova, E. V.
    Kachanova, M. V.
    Zabolotneva, Yu. A.
    Tarasov, S. A.
    Dugina, Yu. L.
    Sergeeva, S. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (03) : 486 - 488
  • [47] Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis
    V. I. Petrov
    A. R. Babaeva
    E. V. Cherevkova
    M. V. Kachanova
    Yu. A. Zabolotneva
    S. A. Tarasov
    Yu. L. Dugina
    S. A. Sergeeva
    Bulletin of Experimental Biology and Medicine, 2009, 148 : 486 - 488
  • [48] LONG-TERM OUTCOME OF TREATMENT WITH SULFASALAZINE IN RHEUMATOID-ARTHRITIS
    SITUNAYAKE, RD
    MCCONKEY, B
    DRUGS, 1986, 32 : 71 - 72
  • [49] ALCLOFENAC IN LONG-TERM TREATMENT OF RHEUMATOID-ARTHRITIS (RA)
    AYLWARD, M
    DAVIES, DBS
    PARKER, RJ
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1975, 4 : 1313 - 1313
  • [50] IBUPROFEN LYSINATE IN THE LONG-TERM TREATMENT OF RHEUMATOID-ARTHRITIS
    PAVELKA, K
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1986, 45 (04): : 228 - 228
12345